Alex Nie

Sheppard, Mullin, Richter & Hampton LLP

$ $$$

Lytton Avenue 379
Palo Alto 94301 CA US

Dr. Alex Y. Nie is a partner in the Intellectual Property Practice Group in the firm’s Palo Alto office. Dr. Nie’s practice focuses on global intellectual property (IP) protection strategy and technology transfer issues, including patent procurement and enforcement, IP valuation and monetization, licensing, and technology transfer.

Dr. Nie’s multidisciplinary technical background enables him to advise a broad spectrum of technology companies on patent issues. His technical training includes a Ph.D. degree in biochemistry, a M.S. degree in computer science and graduate courses in statistics and engineering. Within biotechnology, Dr. Nie’s focus includes biologics, pharmaceutics, in vitro diagnostics, and stem cell technology. In high technology, Dr. Nie works with industry and academic clients in the fields of autonomous driving, artificial intelligence, data mining and data security.

Dr. Nie’s diverse technical background helps him address patent issues in interdisciplinary technologies, such as personalized medicine, pharmacogenomics, biomedical instrumentation (e.g., next generation sequencing), digital and mobile health and in general computational biology and chemistry.

Born in China and being a native Chinese speaker, Dr. Nie is active in US-China legal practice. Dr. Nie advises multinational companies on technology transfer and M&A deals with Chinese companies and represents Chinese technology companies in their expansion to the US market.

Dr. Nie was a former President and a current board member of Chinese American Lawyers of the Bay Area (CALOBA), a major Chinese lawyers’ association in the US. He is a member of BayHelix, an organization of leaders of Chinese heritage in the global life sciences and healthcare community. He was also the Director of the 2013 Annual Conference of Hua Yuan Science and Technology Association (HYSTA), the signature event of Silicon Valley’s most prestigious entrepreneurship organization connecting China and the US.

Earlier, Dr. Nie was part of a US delegation to discuss IP enforcement issues with China’s State Council and represented California Institute for Regenerative Medicine (CIRM), California’s Stem Cell Agency, to negotiate a collaboration agreement with China’s Ministry of Science and Technology.

Prior to his legal career, Dr. Nie was a senior scientist with Johnson & Johnson Pharmaceutical R&D, L.L.C. During his seven-year tenure at the company, Dr. Nie developed new biomarkers for drug safety evaluation using genomics, machine learning and statistical approaches. He was a Johnson & Johnson representative to the Critical Path Institute, an industry-wide collaborative effort to improve the drug approval process.

Dr. Nie has published 26 peer-reviewed scientific articles and two book chapters. He received an NIH grant and has served as a committee member for various scientific organizations, including the International Life Science Institute/Health and Environment Sciences Institute (ILSI-HESI), the Critical Path Institute, and FDA’s HL7/CDISC/I3C Pharmacogenomics Data Standards Committee.

He was a session chairman and invited speaker at the Drug Information Association (DIA)’s 2006 annual conference in Paris. Dr. Nie is a member of the State Bar of California, and is registered to practice before the United States Patent and Trademark Office.

Education:

  • J.D., Rutgers School of Law, 2008
  • Ph.D., Rutgers University, 2001
  • M.S., Rutgers University, 2001
  • M.S., University of Science and Technology of China, 1996
  • B.S., Wuhan University, 1993

Admissions:

  • California
  • U.S. Patent and Trademark Office

Cost

Rate : $$$$

Contact for details

Rate and write a review

Your email address will not be published. Required fields are marked *

Is this your profile?Claim it now.

Make sure your information is up to date.
Lytton Avenue 379
Palo Alto 94301 CA US
Get directions

Lina Stillman

5.0
Broadway 42
New York 10006 NY US
Advertisement